Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | 156.7B | 45.4B | 251.7B | 254.0B |
| Cost of revenue | — | — | — | — |
| Gross profit | — | — | — | — |
| Operating expense | ||||
| Research & development | — | — | — | — |
| Selling general and admin | 978.4M | 1.1B | 1.3B | 2.0B |
| Other operating expenses | 3.0B | 2.8B | 1.6B | 1.4B |
| Operating income | — | — | — | — |
| Non operating interest income | ||||
| Income | — | — | — | — |
| Expense | — | — | — | — |
| Other income expense | 0 | 0 | 0 | 0 |
| Pretax income | 4.1B | 3.7B | 2.9B | 2.6B |
| Tax provision | 276.3M | 497.5M | 342.5M | 345.3M |
| Net income | 3.9B | 3.2B | 2.5B | 2.2B |
| Basic EPS | — | 2.3 | 1.7 | 1.6 |
| Diluted EPS | — | 2.2 | 1.7 | 1.6 |
| Basic average shares | — | 1.4B | 1.4B | 1.4B |
| Diluted average shares | — | 1.5B | 1.4B | 1.4B |
| EBITDA | — | — | — | — |
| Net income from continuing op. | — | — | — | — |
| Minority interests | — | — | — | — |
| Preferred stock dividends | — | — | — | — |